Role of anti‐Naka antibody, monocytes and platelets in the development of transfusion‐related acute lung injury

Authors:

Abstract
Background and Objectives  Transfusion‐related acute lung injury (TRALI) is one of the most serious side‐effects of transfusion. We report here the first two cases of TRALI caused by anti‐Naka (anti‐CD36) antibody from a single blood donor. The aim of this study was to clarify the role of the anti‐Naka antibody in TRALI development.Materials and Methods  Human lung microvascular endothelial cells were co‐cultured with Naka‐positive monocytes and Naka‐positive platelets together with serum prepared from blood products of a TRALI‐caused anti‐Naka antibody‐carrying donor. Expressions of leukotriene B4 (LTB4) and tumour necrosis factor α (TNF‐α) in the co‐culture supernatants were determined.Results  The expressions of LTB4 and TNF‐α were found to be markedly increased, particularly in the presence of both Naka‐positive monocytes and platelets. The expressions of these mediators were almost completed within 4 h after the initiation of co‐culture. Monocyte contribution seemed to be stronger than that of platelets. In the absence of human lung microvascular endothelial, no significant LTB4 or TNF‐α release was observed.Conclusion  Anti‐Naka antibody may be strongly implicated in lung microvascular endothelial dysfunctions that lead to TRALI in a monocyte‐ and platelet‐dependent manner.

This publication has 24 references indexed in Scilit: